Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

WORD

HTML

1442

Tables (1-5)

274

Sum=1804

Publishing Process of This Article

Item

Count

Browse

127

Download

340

Sum=467

Sep 16, 2023 (publication date) through Nov 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 16, 2023; 11(26): 6066-6072
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6066

Table 1 Comparison of the clinical outcomes between the two study groups, n (%)

Citation: Li F, Li H, Luo R, Pei JB, Yu XY. Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation. World J Clin Cases 2023; 11(26): 6066-6072
URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6066.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6066